Mitchell Emily, Pham My H, Clay Anna, Sanghvi Rashesh, Williams Nicholas, Pietsch Sandra, Hsu Joanne I, Jung Hyunchul, Vedi Aditi, Moody Sarah, Wang Jingwei, Leonganmornlert Daniel, Spencer Chapman Michael, Dunstone Ellie, Santarsieri Anna, Cagan Alex, Machado Heather E, Baxter E Joanna, Follows George, Hodson Daniel J, McDermott Ultan, Doherty Gary J, Martincorena Inigo, Humphreys Laura, Mahbubani Krishnaa, Saeb Parsy Kourosh, Takahashi Koichi, Goodell Margaret A, Kent David, Laurenti Elisa, Campbell Peter J, Rahbari Raheleh, Nangalia Jyoti, Stratton Michael R
Wellcome Sanger Institute, Hinxton, UK.
Wellcome-MRC Cambridge Stem Cell Institute, Cambridge Biomedical Campus, Cambridge, UK.
Nat Genet. 2025 Jul 1. doi: 10.1038/s41588-025-02234-x.
Several chemotherapeutic agents act by increasing DNA damage in cancer cells, triggering cell death. However, there is limited understanding of the extent and long-term consequences of collateral DNA damage in normal tissues. To investigate the impact of chemotherapy on mutation burdens and the cell population structure of normal tissue, we sequenced blood cell genomes from 23 individuals aged 3-80 years who were treated with a range of chemotherapy regimens. Substantial additional somatic mutation loads with characteristic mutational signatures were imposed by some chemotherapeutic agents, but the effects were dependent on the drug and blood cell types. Chemotherapy induced premature changes in the cell population structure of normal blood, similar to those caused by normal aging. The results show the long-term biological consequences of cytotoxic agents to which a substantial fraction of the population is exposed as part of disease management, raising mechanistic questions and highlighting opportunities for the mitigation of adverse effects.
几种化疗药物通过增加癌细胞中的DNA损伤来发挥作用,从而引发细胞死亡。然而,对于正常组织中附带DNA损伤的程度和长期后果,人们了解有限。为了研究化疗对正常组织突变负担和细胞群体结构的影响,我们对23名年龄在3至80岁之间、接受了一系列化疗方案治疗的个体的血细胞基因组进行了测序。一些化疗药物施加了具有特征性突变特征的大量额外体细胞突变负荷,但其影响取决于药物和血细胞类型。化疗诱导了正常血液细胞群体结构的过早变化,类似于正常衰老所引起的变化。结果显示了细胞毒性药物对相当一部分人群作为疾病管理一部分所暴露的长期生物学后果,引发了机制问题,并突出了减轻不良反应的机会。